<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220424054640N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-14</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Superficial Keratotomy on Reducing Postoperative Pain Fallowing Conjuctival Flap.</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Superficial Keratotomy on Reducing Postoperative Pain Fallowing Conjuctival Flap ;a Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>16</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63334</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: Patients are divided into two groups. In the first group, we use the classical Gunderson technique as the surgical procedure . In the second group, we use the modified surgical method, the conj flap operation with cutting the superficial nerves of the cornea. All surgeries are performed under general anesthesia. In surgery, a knife is used and the depth of the incisions is enough to reach the midd stroma. Trephinen will also be used in cases where the diameter of the cornea is higher than 8 mm. It will be used and we will cut it. After the pan-pressure operation, pressure will be applied for three days and 5 acetaminophen tablets will be prescribed for all patients with a prescription every 4 hours. If the patient needs more painkillers, in Patient data are recorded. Due to the fact that the patient's eye is bandaged in the first three days, we will not use topical corticosteroids for up to three days after opening the bandage, which coincides with the first visit on the third day after surgery. Topical steroid drops should be started four times a day for the patient and no oral corticosteroids should be used. The title of the cutting guide will be used after the trephinen horizontal and vertical cuts on the surface of the century One will be done by the surgeon with a knife at the same depth of 300. In cases where the diameter of the cornea is less than 8 mm, the surgeon tries to extend the incision depth to the middle of the stroma. After 6 hours, 24 hours and 48 hours after surgery, both groups of patients are asked to express their pain on the VAS scale. Visual analogue scale (VAS) is one of the best methods available for estimating pain intensity. VAS is a 10 cm line printed on a piece of paper with a marker at the end. It is "painless" at one end and "worst pain" or "indescribable pain" at the other. The patient places a mark on the line to indicate pain, and then the mark is measured with a ruler to obtain a score. The mean scores of the two groups are calculated using the Tscore method and finally the mean postoperative pain intensity in the two selected groups will be compared, Randomization description: For random assignment of patients to two groups, random codes in balanced quadruple blocks will be used as follows:
1.AA BB
2.AB AB
3.BB AA
4.BA BA, Blinding description: Researcher number two is responsible for asking  how much pain  the patient has at 6 24 48 hours after the operation and at the time of question he is unaware that the patient belongs to the intervention or control group. (Blind access).</study_design>
      <phase>3</phase>
      <hc_freetext>Severe visual impairment, monocular.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:we use the modified surgical method, the conj flap operation with cutting the superficial nerves of the cornea. Intervention 2: Control group:we use the classical Gunderson technique as the surgical procedure.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
We intend to share the results as an article

When:
At the end of project 1 year

To whom:
All

Conditions:
All academic research

Where to obtain:
Dr karimi instagram  @drnasserkarimi

How to obtain:
Within 1 week of request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.Nasser Karimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Niyayesh St., Satarkhan St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 6655 8811</telephone>
        <email>drnasserkarimi@gmai.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasser Karimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Niyayesh street, Satarkhan street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445613131</zip>
        <telephone>+98 21 6655 8811</telephone>
        <email>drnasserkarimi@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>VLE (vision loss eye) Patients who are candidates for prosthesis implantation</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who are candidates for conjunctival flap with indications other than implant placement (such as pain due to corneal ulcers, etc.)
painful vision loss eye</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Severe visual impairment, monocular</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:we use the modified surgical method, the conj flap operation with cutting the superficial nerves of the cornea.</i_keyword>
      <i_keyword>Control group:we use the classical Gunderson technique as the surgical procedure</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>In the study of the effect of superficial corneal incisions in reducing pain in patients after conjunctival flap surgery, primary outcome can be the pain score  after Corneal neurotomy . Timepoint: In the study of the effect of superficial corneal incisions in reducing pain in patients after conjunctival flap surgery, pain score measurement  can be 6 24 48 hours after corneal neurotomy. Method of measurement: In studying the effect of superficial corneal incisions in reducing pain in patients after conjunctival flap surgery, how to measure pain score can be using VSA(visual analogue scale ).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-18</approval_date>
        <contact_name>Ethics Committee of Iran  university of medical sciences</contact_name>
        <contact_address>Niyayesh St., Satarkhan St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
